✦ LIBER ✦

Clinical study on treatment of advanced non-small cell lung cancer by arsenious acid combined with Ta-1 thymus peptide and megestrol acetate

✍ Scribed by Yue-Feng Guo, Zhi-Min Jiao

Book ID: 118294582
Publisher: Chinese Association of Traditional and Western Medicine
Year: 2002
Tongue: English
Weight: 453 KB
Volume: 8
Category: Article
ISSN: 1672-0415
DOI: 10.1007/bf02934400

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical study on concurrent chemoradiot

Clinical study on concurrent chemoradiotherapy combined with Kanglaite injection in the treatment of regionally advanced unresectable non-small cell lung cancer

✍ Xiaojun Qiu; Jianbo Ma; Bin Ji; Hongyu Zhao; Yan Wang 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 192 KB

Clinical study on treatment of non-small

Clinical study on treatment of non-small cell lung cancer by chinese herbal medicine combined with bronchial arterial chemotherapy

✍ Cheng-lin Liu; Yuan-dong Wang; Yuan-dong Jin; Li-ping Liu; Qing-wei Yu; Yu-cheng 📂 Article 📅 2001 🏛 Chinese Association of Traditional and Western Med 🌐 English ⚖ 470 KB

Clinical study on concurrent and sequent

Clinical study on concurrent and sequential therapy of intensity modulated radiation therapy (IMRT) combined with NP regimen chemotherapy in the treatment of middle and advanced non-small cell lung cancer

✍ Xiaodong Jiang; Da’an Song; Weiming Zhang; Jin Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 184 KB

Phase II study with thymosin α1 (TA1), i

Phase II study with thymosin α1 (TA1), interferon α2a (IFN), cisplatin (DDP) and etoposide (VP16) in the treatment of advanced non small cell lung cancer (NSCLS)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Phase II study of ASA404 (vadimezan, 5,6

Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

✍ McKeage, Mark J.; Reck, Martin; Jameson, Michael B.; Rosenthal, Mark A.; Gibbs, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 250 KB

A phase II study of days 1 and 8 combina

A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status

✍ Cobo, Manuel; Gutiérrez, Vanesa; Alcaide, Julia; Alés, Inmaculada; Villar, Esthe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB